[go: up one dir, main page]

BE626279A - - Google Patents

Info

Publication number
BE626279A
BE626279A BE626279DA BE626279A BE 626279 A BE626279 A BE 626279A BE 626279D A BE626279D A BE 626279DA BE 626279 A BE626279 A BE 626279A
Authority
BE
Belgium
Prior art keywords
chloro
diethyl
oxide
acid addition
weight
Prior art date
Application number
Other languages
English (en)
French (fr)
Publication of BE626279A publication Critical patent/BE626279A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE626279D BE626279A (ja)

Publications (1)

Publication Number Publication Date
BE626279A true BE626279A (ja)

Family

ID=197151

Family Applications (1)

Application Number Title Priority Date Filing Date
BE626279D BE626279A (ja)

Country Status (1)

Country Link
BE (1) BE626279A (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216555A2 (en) * 1985-09-11 1987-04-01 Btg International Limited Use of dioxopiperidine derivatives in the treatment of anxiety, for the reduction of chronic abnormally high brain levels of serotonin or 5-hydroxy-indoleacetic acid, and in the treatment of bacterial or viral infections

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216555A2 (en) * 1985-09-11 1987-04-01 Btg International Limited Use of dioxopiperidine derivatives in the treatment of anxiety, for the reduction of chronic abnormally high brain levels of serotonin or 5-hydroxy-indoleacetic acid, and in the treatment of bacterial or viral infections
EP0216555A3 (en) * 1985-09-11 1989-11-23 National Research Development Corporation Use of dioxopiperidine derivatives in the treatment of anxiety, for the reduction of chronic abnormally high brain levels of serotonin or 5-hydroxy-indoleacetic acid, and in the treatment of bacterial or viral infections
EP0452765A2 (en) * 1985-09-11 1991-10-23 Btg International Limited Pharmaceutical composition and medical uses of dioxopiperidine derivatives, especially as immune response potentiators, antiviral and antibacterial agents
EP0452765A3 (en) * 1985-09-11 1992-06-10 National Research Development Corporation Pharmaceutical composition and medical uses of dioxopiperidine derivatives, especially as immune response potentiators, antiviral and antibacterial agents

Similar Documents

Publication Publication Date Title
US5021456A (en) Inhibitors of lysyl oxidase
US5182297A (en) Inhibitors of lysyl oxidase
FR2658511A1 (fr) Nouveaux derives de benzimidazole et d'azabenzimidazole, antagonistes des recepteurs au thromboxane; leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2492258A1 (fr) Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
CH657359A5 (fr) Derives d'indole, procedes pour leur preparation et composition pharmaceutique les contenant.
JP2003522724A (ja) 医薬製剤のための酸化防止剤−安定剤系
US20070203212A1 (en) Method of treating osteoarthritis
CH635328A5 (en) Derivatives of N-(5-tetrazolyl)benzamide and pharmaceutical composition containing them
KR100427003B1 (ko) 연골 손상의 치료 방법
JPS63264421A (ja) 高脂質血症治療剤
US20030199567A1 (en) Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
FR2521134A1 (fr) Urees et thio-urees substituees, leur procede de preparation et leur application therapeutique comme medicaments anti-atherosclereux
BE626279A (ja)
AU2003255937A1 (en) Method of treating osteoarthritis
FR2467840A1 (fr) Acides benzoyl-3 nitro-2 phenylacetiques et sels metalliques, amides et esters correspondants utiles notamment comme medicaments anti-inflammatoires compositions therapeutiques et formes pharmaceutiques les contenant et procedes et intermediaires pour leur preparation
LV11818B (en) Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
JP2772660B2 (ja) リシルオキシダーゼの抑制剤
FR2472387A1 (fr) Compositions pharmaceutiques pour le traitement de l'oedeme pulmonaire aigu, de certains etats de choc et de l'hyperfibrinolyse
EP0575481A1 (fr) Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4.
MXPA04005557A (es) Metodo para tratar la osteoartritis.
JPH07252143A (ja) 認知増強を誘導するベンラファキシン含有医薬組成物
BE711349A (ja)
BE620468A (ja)
GB2052982A (en) Therapeutic combinations
BE564356A (ja)